SCHEMBL19863086

SCHEMBL19863086

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-n4c5ccccc5c5c6oc7ccccc7c6cc(-c6nc(-c7ccccc7)nc(-c7ccccc7)n6)c54)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.36
TSHR P16473 5/20 0.36
ALDH1A1 P00352 5/20 0.34
KMT2A Q03164 4/20 0.34
POLB P06746 3/20 0.34
HSD17B10 Q99714 3/20 0.34
MEN1 O00255 3/20 0.34
BRCA1 P38398 1/20 0.34
LMNA P02545 4/20 0.34
KDM4E B2RXH2 3/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.33
USP2 O75604 1/20 0.33
HTT P42858 1/20 0.33
SIRT2 Q8IXJ6 1/20 0.32
SIRT1 Q96EB6 1/20 0.32
ALOX5 P09917 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863157 0.97 ALDH1A1 (0.37) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863094 0.96 MAPT (0.37) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863166 0.92 KDM4E (0.33) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863161 0.92 KDM4E (0.35) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL18593782 0.92 MAPT (0.37) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863084 0.92 MAPT (0.35) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863083 0.91 MAPT (0.36) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL18594139 0.91 MAPT (0.37) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL19863042 0.90 KDM4E (0.35) MAPTTSHRALDH1A1KMT2APOLB
SCHEMBL18593673 0.90 KDM4E (0.35) MAPTTSHRALDH1A1KMT2APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.